IRulya Therapeutics Inc. Common Stock

IRLANASDAQ • USD
39.88 USD
↘ 0.06 (0.15%)AT CLOSE (03:59 PM EST)
39.29
↘ 0.59 (1.48%)
POST MARKET (AS OF 06:07 PM EST)
Post Market
AS OF 06:07 PM EST
39.29
↘ 0.59 (1.48%)
🟢Market: OPEN

IRulya Therapeutics Inc. Common Stock (IRLA) trades at $39.29 per share. Technical indicators currently signal "Buy". Key drivers include a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Nov 20, 2026.

Open?$39.05
High?$42.00
Low?$38.92
Prev. Close?$39.94
Volume?200.7K
Avg. Volume?N/A
VWAP?$40.21
Bid / Ask
Bid?$30.35 × 100
Ask?$49.23 × 100
Spread?$18.88
Midpoint?$39.79
Valuation & Ratios
Market Cap?433.0M
Shares Out?10.8M
Float?899.2K
Float %?88.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
IRulya Therapeutics Inc is committed to transforming the lives of patients with serious, underserved diseases by developing disease-modifying therapies. The company is currently developing LAM-001 for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD), bronchiolitis obliterans syndrome post-lung transplant (BOS), and sarcoidosis-associated pulmonary hypertension (SAPH). A Phase 2a study in PH patients has been completed; a Phase 2 clinical study in BOS patients is ongoing; a Phase 2b clinical study in PH-ILD is ongoing; and a Phase 2 clinical study in SAPH is ongoing.
Employees
38
Market Cap
433.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2019-05-09
Address
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO, CA 94080
Phone: 415-910-5717
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?14.21%High
Short Interest?127.8K
Days to Cover?1.1
Free Float899.2K
Avg Daily Volume112.7K
Settlement Date2026-10-30